KHKazuki Hama

Kazuki Hama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kazuki Hama has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial intelligence-assisted endoscopic ultrasonography for the detection of a small T1 pancreatic ductal adenocarcinoma in a difficult-to-puncture location

    by Yukitoshi Matsunami, Shuntaro Mukai, Hirohito Minami, Kazuki Hama, Takao Itoi

  • Open Access

    Endoscopic Step‐up Approach for Walled‐off Necrosis After Acute Pancreatitis

    by Shuntaro Mukai, Atsushi Sofuni, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Yukitoshi Matsunami, Kazumasa Nagai, Hiroyuki Kojima, Hirohito Minami, Noriyuki Hirakawa, et al.

    This review outlines current interventional strategies for treating symptomatic walled‐off necrosis (WON) after necrotizing pancreatitis. Mortality from acute pancreatitis has improved, but late mortality, particularly from infected necrosis, remains a challenge. WON requires invasive treatment in cases of infection or symptoms. A step‐up approach is recommended, in which minimally invasive drainage is performed first, followed by more invasive treatments if the effect is insufficient. Among these, an endoscopic step‐up approach mainly consisting of transmural treatment using endoscopic ultrasound‐guided drainage and endoscopic necrosectomy (EN) has been reported with favorable outcomes. The use of lumen‐apposing metal stents (LAMSs) has enhanced drainage efficiency and facilitated EN, although bleeding and stent‐related adverse events remain concerns. Recent techniques such as multiple transluminal gateways and transcystic drainage have improved outcomes for complex, multilocular WON. With the introduction of the LAMS and additional endoscopic drainage techniques, most cases can be successfully treated with endoscopic therapy alone. However, endoscopic treatment alone has limitations for lesions spreading to the pelvic cavity, and a combination of percutaneous treatment or surgical treatment should be considered.


  • Open Access

    Giant pancreatic stentolith after chronic transgastric pancreatic duct drainage

    by Kazuki Hama, Shuntaro Mukai, Takayoshi Tsuchiya, Ryosuke Tonozuka, Kenjiro Yamamoto, Kazumasa Nagai, Yukitoshi Matsunami, Takao Itoi

  • Open Access

    Endoscopic ultrasound-guided drainage of bilomas in difficult-to-puncture locations using a sheath-assisted puncture technique

    by Kazuki Hama, Yukitoshi Matsunami, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Shuntaro Mukai, Takao Itoi

    Biloma is a complication of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) [1]. Despite being the first-line treatment for infected bilomas, percutaneous drainage can affect daily life and pose self-extraction risks, particularly in older patients [2]. Endoscopic ultrasound (EUS)-guided drainage offers a viable alternative for internal biliary drainage; however, it can be challenging for the right liver lobe because of its long distance from the gastrointestinal (GI) tract [3] [4] [5]. Here, we describe successful EUS-guided drainage of an infected biloma distant from the GI tract using a sheath-assisted puncture technique ([Fig. 1], [Video 1]). An 85-year-old man who developed an infected biloma in the posterior liver segment after TACE for HCC ([Fig. 2] a) opted for endoscopic transpapillary drainage because of advanced age and high risk of self-extraction. However, uncontrollable infections necessitated EUS-guided transduodenal drainage with a nasal drainage tube. Biloma recurrence in segment 7 induced an initial reintervention attempt utilizing a guidewire along the tube ([Fig. 2] b). Difficulty in passing the guidewire into the biloma cavity prompted additional EUS-guided transduodenal drainage. A convex EUS scope (GIF-UCT260; Olympus, Tokyo, Japan) visualized the deeper residual biloma, which required puncturing. However, the 19G needle (EZ shot 3 plus; Olympus) did not reach the target, even at its maximum extent ([Fig. 3] a). A deep puncture was made to reach the target by pushing the sheath ([Fig. 3] b). After reconfirming the needle tip in the biloma using contrast, a 0.025-inch guidewire (VisiGlide II; Olympus) was placed, followed by insertion of a 5-Fr nasal drainage tube ([Fig. 2] c, d). Post-procedural computed tomography confirmed biloma shrinkage and well-controlled infection. The patient was discharged on postprocedural day 10 with no adverse events. The 19G needle has a 2.6-mm sheath, which allows safe sheath-assisted puncture without damaging the gastric mucosa and liver parenchyma. Endoscopy_UCTN_Code_TTT_1AS_2AH Article published online: 28 January 2025 © 2024. The Author(s). This article was originally published by Thieme in Endoscopy 2024; 56: E874–E875 as an open access article under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    A novel plastic stent to prevent dislocation after endoscopic ultrasound-guided gallbladder drainage

    by Kazuki Hama, Hiroyuki Kojima, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Shuntaro Mukai, Takao Itoi

    Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) using plastic stents had been originally developed for patients unfit for surgery [1] [2]. Lumen-apposing metal stents (LAMSs) are being widely used due to their superior drainage capability and ease of deployment [3]. However, LAMSs are not designed for permanent placement, and subsequent internal fistulization with plastic stents is typically required to maintain long-term drainage [4]. Conventional double-pigtail plastic stents may be insufficient to maintain large fistula tracts, with the risks of spontaneous dislocation and recurrence of cholecystitis. To address this limitation, we developed a novel plastic stent specifically designed to prevent dislocation ([Fig. 1]; [Video 1]). A 60-year-old man with a history of cerebral infarction presented with right hemiplegia and severe dysphagia. Communication was limited, and percutaneous endoscopic gastrostomy (PEG) was considered. During hospitalization, he developed acute cholecystitis due to gallstones. Because of his poor general condition, surgical cholecystectomy was deemed unfeasible, and the patient was classified as a “never surgery” case. EUS-GBD was performed using a 10-mm LAMS system (Hot AXIOS; Boston Scientific Co.) ([Fig. 2]). Drainage was effective, and clinical inflammation subsided rapidly. Three weeks later, the LAMS was removed, and a newly designed plastic stent was placed to maintain the cholecystoenteric fistula ([Fig. 3]). This novel stent features an anti-migration design and sufficient caliber to maintain fistula patency while minimizing the risk of spontaneous dislocation. After placement, the patient showed no signs of stent dislocation, occlusion, or recurrent infection. No re-intervention was necessary, and clinical progress remains favorable ([Fig. 4]). This case highlights the potential clinical utility of the new plastic stent as a bridging device after LAMS removal in EUS-GBD. It may offer a safer and more reliable long-term internal drainage option for patients who are not surgical candidates. Endoscopy_UCTN_Code_TTT_1AS_2AH Article published online: 11 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    Endoscopic radical treatment of a giant ampullary tumor with biliopancreatic duct extensions using multimodality approaches

    by Kazuki Hama, Kenjiro Yamamoto, Takayoshi Tsuchiya, Ryosuke Tonozuka, Shuntaro Mukai, Kazumasa Nagai, Yukitoshi Matsunami, Takao Itoi

  • Open Access

    Troubleshooting the migration of endoscopic ultrasound‐guided pancreatic duct drainage stent to avoid repuncture

    by Kazuki Hama, Reina Tanaka, Takao Itoi

    Watch a video of this article.

  • Open Access

    Recent advancements in image‐enhanced endoscopy in the pancreatobiliary field

    by Haruka Toyonaga, Tsuyoshi Hayashi, Kazuki Hama, Ryo Ando, Tatsuya Ishii, Kenta Yoshida, Toshifumi Kin, Masayo Motoya, Kuniyuki Takahashi, Akio Katanuma

    Image‐enhanced endoscopy (IEE) has advanced gastrointestinal disease diagnosis and treatment. Traditional white‐light imaging has limitations in detecting all gastrointestinal diseases, prompting the development of IEE. In this review, we explore the utility of IEE, including texture and color enhancement imaging and red dichromatic imaging, in pancreatobiliary (PB) diseases. IEE includes methods such as chromoendoscopy, optical‐digital, and digital methods. Chromoendoscopy, using dyes such as indigo carmine, aids in delineating lesions and structures, including pancreato‐/cholangio‐jejunal anastomoses. Optical‐digital methods such as narrow‐band imaging enhance mucosal details and vessel patterns, aiding in ampullary tumor evaluation and peroral cholangioscopy. Moreover, red dichromatic imaging with its specific color allocation, improves the visibility of thick blood vessels in deeper tissues and enhances bleeding points with different colors and see‐through effects, proving beneficial in managing bleeding complications post‐endoscopic sphincterotomy. Color enhancement imaging, a novel digital method, enhances tissue texture, brightness, and color, improving visualization of PB structures, such as PB orifices, anastomotic sites, ampullary tumors, and intraductal PB lesions. Advancements in IEE hold substantial potential in improving the accuracy of PB disease diagnosis and treatment. These innovative techniques offer advantages paving the way for enhanced clinical management of PB diseases. Further research is warranted to establish their standard clinical utility and explore new frontiers in PB disease management.


  • Open Access

    Noninvasive rapid urinary trypsinogen‐2 dipstick test for early exclusion of post‐endoscopic retrograde cholangiopancreatography pancreatitis within hours after endoscopic retrograde cholangiopancreatography: Clinical diagnosis and considerations

    by Kazuki Hama, Atsushi Sofuni, Ryosuke Nakatsubo, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Shuntaro Mukai, Kenjiro Yamamoto, Akio Katanuma, Takao Itoi

    Objective: Few reports have explored the application of urinary trypsinogen‐2 measurement in the early diagnosis of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, and none have demonstrated the benefits of noninvasive testing. This study aimed to evaluate the clinical application of the rapid urinary trypsinogen‐2 dipstick test (Nipro, Japan) compared with serum amylase and lipase levels for the early diagnosis of post‐ERCP pancreatitis (PEP).Methods: A total of 100 consecutive patients (54 men and 46 women) who were admitted and underwent ERCP at Tokyo Medical University Hospital from August 2021 to December 2021 were recruited. All patients underwent rapid urinary trypsinogen‐2 measurement using the dipstick test before and after ERCP. Measurements were taken 24 h before ERCP for pre‐ERCP and 1–4 h after ERCP for post‐ERCP. Additionally, serum amylase and lipase levels were measured at 8:00 a.m. of the day after ERCP (at least 8 h after ERCP), and their diagnostic abilities for PEP were compared and evaluated.Results: PEP occurred in 5/100 patients (5%). The sensitivity, specificity, positive predictive value, and negative predictive value of the dipstick test for diagnosing PEP were 100%, 83.2%, 23.8%, and 100%, respectively. These results were comparable to the diagnostic performance of serum amylase and lipase levels at 8:00 a.m. on the day after ERCP (at least 8 h after ERCP). However, false positives must be considered.Conclusion: The dipstick test may be useful in clinical practice as a noninvasive screening test for the early prediction of PEP.


  • Open Access

    Endoscopic ultrasound-guided drainage of bilomas in difficult-to-puncture locations using a sheath-assisted puncture technique

    by Kazuki Hama, Yukitoshi Matsunami, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Shuntaro Mukai, Takao Itoi

    Biloma is a complication of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) [1]. Despite being the first-line treatment for infected bilomas, percutaneous drainage can affect daily life and pose self-extraction risks, particularly in older patients [2]. Endoscopic ultrasound (EUS)-guided drainage offers a viable alternative for internal biliary drainage; however, it can be challenging for the right liver lobe because of its long distance from the gastrointestinal (GI) tract [3] [4] [5]. Here, we describe successful EUS-guided drainage of an infected biloma distant from the GI tract using a sheath-assisted puncture technique ([Fig. 1], [Video 1]). An 85-year-old man who developed an infected biloma in the posterior liver segment after TACE for HCC ([Fig. 2] a) opted for endoscopic transpapillary drainage because of advanced age and high risk of self-extraction. However, uncontrollable infections necessitated EUS-guided transduodenal drainage with a nasal drainage tube. Biloma recurrence in segment 7 induced an initial reintervention attempt utilizing a guidewire along the tube ([Fig. 2] b). Difficulty in passing the guidewire into the biloma cavity prompted additional EUS-guided transduodenal drainage. A convex EUS scope (GIF-UCT260; Olympus, Tokyo, Japan) visualized the deeper residual biloma, which required puncturing. However, the 19G needle (EZ shot 3 plus; Olympus) did not reach the target, even at its maximum extent ([Fig. 3] a). A deep puncture was made to reach the target by pushing the sheath ([Fig. 3] b). After reconfirming the needle tip in the biloma using contrast, a 0.025-inch guidewire (VisiGlide II; Olympus) was placed, followed by insertion of a 5-Fr nasal drainage tube ([Fig. 2] c, d). Post-procedural computed tomography confirmed biloma shrinkage and well-controlled infection. The patient was discharged on postprocedural day 10 with no adverse events. The 19G needle has a 2.6-mm sheath, which allows safe sheath-assisted puncture without damaging the gastric mucosa and liver parenchyma. Endoscopy_UCTN_Code_TTT_1AS_2AH Article published online: 14 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany